NCT00453479View on ClinicalTrials.gov

A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B.

PHASE2CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

March 28, 2007

Primary Completion Date

October 11, 2007

Study Completion Date

October 11, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK233705B

Trial Locations (4)

5623 EJ

GSK Investigational Site, Eindhoven

3844 DG

GSK Investigational Site, Harderwijk

3584 CJ

GSK Investigational Site, Utrecht

9471 GP

GSK Investigational Site, Zuidlaren

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00453479 - A Dose Ascending, Study To Examine The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of GSK233705B. | Biotech Hunter | Biotech Hunter